| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |